GE HealthCare Technologies (GEHC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $69.57, -1.11% vs the prior close of $70.35.
- Volume 3.11M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GEHC dips 1.1% to $69.57. Closed at $69.57, -1.11% vs the prior close of $70.35. Day range $69.45–$71.32, opened at $71.10.
GEHC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — GEHC dips 1.1% to $69.57
- Closed at $69.57, -1.11% vs the prior close of $70.35. Day range $69.45–$71.32, opened at $71.10.
- Volume was 3.11M shares, 0.9x its 50-day average of 3.30M.
- Price is +1.4% vs its 50-day average ($68.59) and -1.3% vs its 200-day average ($70.47).
- 52-week range $58.75–$89.77; today's close sits at 35% of that range, 22.5% below the 52-week high.
Oct 15, 2026 — GEHC rises 2.7% to $70.35, a 1-month high
- Closed at $70.35, +2.75% vs the prior close of $68.47. Day range $69.50–$70.99, opened at $69.80.
- Volume was 3.75M shares, 1.1x its 50-day average of 3.28M.
- Price is +2.5% vs its 50-day average ($68.61) and -0.3% vs its 200-day average ($70.54).
- 52-week range $58.75–$89.77; today's close sits at 37% of that range, 21.6% below the 52-week high.
Oct 14, 2026 — GEHC dips 0.5% to $68.47
- Closed at $68.47, -0.47% vs the prior close of $68.79. Day range $67.66–$69.51, opened at $68.92.
- Volume was 5.03M shares, 1.5x its 50-day average of 3.25M.
- Price is -0.2% vs its 50-day average ($68.61) and -3.0% vs its 200-day average ($70.61).
- 52-week range $58.75–$89.77; today's close sits at 31% of that range, 23.7% below the 52-week high.
Oct 13, 2026 — GEHC rises 1.6% to $68.79, a 1-month high, 3 up days in a row
- Closed at $68.79, +1.55% vs the prior close of $67.74. Day range $67.36–$69.36, opened at $67.74.
- Volume was 3.44M shares, 1.1x its 50-day average of 3.27M.
- Price is +0.2% vs its 50-day average ($68.64) and -2.7% vs its 200-day average ($70.68).
- 52-week range $58.75–$89.77; today's close sits at 32% of that range, 23.4% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — GEHC jumps 3.0% to $67.74, a 1-month high
- Closed at $67.74, +3.04% vs the prior close of $65.74. Day range $65.74–$68.34, opened at $66.01.
- Volume was 3.75M shares, 1.1x its 50-day average of 3.30M.
- Price is -1.3% vs its 50-day average ($68.66) and -4.3% vs its 200-day average ($70.76).
- 52-week range $58.75–$89.77; today's close sits at 29% of that range, 24.5% below the 52-week high.
Oct 9, 2026 — GEHC rises 2.4% to $65.74
- Closed at $65.74, +2.37% vs the prior close of $64.22. Day range $64.29–$65.78, opened at $64.34.
- Volume was 2.86M shares, 0.8x its 50-day average of 3.39M.
- Price is -4.3% vs its 50-day average ($68.67) and -7.2% vs its 200-day average ($70.83).
- 52-week range $58.75–$89.77; today's close sits at 23% of that range, 26.8% below the 52-week high.
Oct 8, 2026 — GEHC dips 0.7% to $64.22, 3 down days in a row
- Closed at $64.22, -0.70% vs the prior close of $64.67. Day range $63.31–$64.50, opened at $64.28.
- Volume was 4.95M shares, 1.4x its 50-day average of 3.60M.
- Price is -6.6% vs its 50-day average ($68.75) and -9.5% vs its 200-day average ($70.92).
- 52-week range $58.75–$89.77; today's close sits at 18% of that range, 28.5% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — GEHC ends flat (-0.2%) to $64.67
- Closed at $64.67, -0.15% vs the prior close of $64.77. Day range $64.03–$65.44, opened at $64.93.
- Volume was 4.07M shares, 1.1x its 50-day average of 3.68M.
- Price is -6.1% vs its 50-day average ($68.91) and -8.9% vs its 200-day average ($71.02).
- 52-week range $58.75–$89.77; today's close sits at 19% of that range, 28.0% below the 52-week high.
Oct 6, 2026 — GEHC dips 1.5% to $64.77
- Closed at $64.77, -1.48% vs the prior close of $65.74. Day range $64.67–$66.55, opened at $66.04.
- Volume was 3.55M shares, 1.0x its 50-day average of 3.73M.
- Price is -6.0% vs its 50-day average ($68.89) and -8.9% vs its 200-day average ($71.11).
- 52-week range $58.75–$89.77; today's close sits at 19% of that range, 27.8% below the 52-week high.
Oct 5, 2026 — GEHC rises 2.3% to $65.74
- Closed at $65.74, +2.26% vs the prior close of $64.29. Day range $63.37–$65.86, opened at $63.62.
- Volume was 4.30M shares, 1.1x its 50-day average of 3.83M.
- Price is -4.5% vs its 50-day average ($68.82) and -7.7% vs its 200-day average ($71.19).
- 52-week range $58.75–$89.77; today's close sits at 23% of that range, 26.8% below the 52-week high.
Oct 2, 2026 — GEHC rises 0.5% to $64.29
- Closed at $64.29, +0.48% vs the prior close of $63.98. Day range $63.96–$64.99, opened at $64.73.
- Volume was 3.24M shares, 0.8x its 50-day average of 3.85M.
- Price is -6.4% vs its 50-day average ($68.72) and -9.8% vs its 200-day average ($71.28).
- 52-week range $58.75–$89.77; today's close sits at 18% of that range, 28.4% below the 52-week high.
GEHC latest news & SEC filings
Every SEC filing by or about GEHC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Grogan William K received an award of 62,256 shares on Sep 14, 2026; now holds 62,256
- Grogan William K received an award of 12,840 shares on Sep 14, 2026; now holds 75,096
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 29, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade GEHC
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Jul 23, 2026, Apr 29, 2026, Feb 4, 2026. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.26% (largest 3.0%).
- Liquidity: about 3.72M shares (≈$258.49M) trade per day on average.
- 52-week position: $69.57 vs a range of $58.75–$89.77 (35% of the range).
- Dividends: last ex-dividend date Jul 24, 2026 ($0.035/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Kevin Lobo bought 10,000 shares on May 22, 2026.
- Latest filings: 8-K Sep 22, 2026; 8-K Aug 18, 2026; 8-K Jul 29, 2026.
- Share count: 454.89M shares outstanding (Apr 22, 2026), -0.7% vs a year earlier.
- Listing: Nasdaq · industry: X-Ray Apparatus & Tubes & Related Irradiation Apparatus.
GEHC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 71.10 | 71.32 | 69.45 | 69.57 | 3.11M |
| Oct 15, 2026 | 69.80 | 70.99 | 69.50 | 70.35 | 3.75M |
| Oct 14, 2026 | 68.92 | 69.51 | 67.66 | 68.47 | 5.03M |
| Oct 13, 2026 | 67.74 | 69.36 | 67.36 | 68.79 | 3.44M |
| Oct 12, 2026 | 66.01 | 68.34 | 65.74 | 67.74 | 3.75M |
| Oct 9, 2026 | 64.34 | 65.78 | 64.29 | 65.74 | 2.86M |
| Oct 8, 2026 | 64.28 | 64.50 | 63.31 | 64.22 | 4.95M |
| Oct 7, 2026 | 64.93 | 65.44 | 64.03 | 64.67 | 4.07M |
| Oct 6, 2026 | 66.04 | 66.55 | 64.67 | 64.77 | 3.55M |
| Oct 5, 2026 | 63.62 | 65.86 | 63.37 | 65.74 | 4.30M |
| Oct 2, 2026 | 64.73 | 64.99 | 63.96 | 64.29 | 3.24M |
| Oct 1, 2026 | 65.37 | 65.54 | 63.86 | 63.98 | 3.31M |
| Sep 30, 2026 | 66.35 | 66.55 | 65.37 | 65.37 | 2.73M |
| Sep 29, 2026 | 66.32 | 66.76 | 65.61 | 66.46 | 3.31M |
| Sep 28, 2026 | 66.29 | 67.10 | 65.96 | 66.78 | 4.17M |
| Sep 25, 2026 | 66.20 | 67.01 | 65.75 | 66.63 | 4.16M |
| Sep 24, 2026 | 66.14 | 66.48 | 65.19 | 66.38 | 3.97M |
| Sep 23, 2026 | 66.16 | 66.46 | 65.62 | 66.09 | 3.17M |
| Sep 22, 2026 | 66.28 | 67.09 | 66.00 | 66.27 | 3.94M |
| Sep 21, 2026 | 64.24 | 65.10 | 63.71 | 64.81 | 3.50M |
About GE HealthCare Technologies
GE HealthCare Technologies (GEHC) is listed on the Nasdaq and classified by the SEC under “X-Ray Apparatus & Tubes & Related Irradiation Apparatus”. Its business address is in CHICAGO, IL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1932393.
GEHC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Peter J Arduini | President and CEO | Sep 4, 2026 |
| H Lawrence Jr Culp | Director | May 11, 2026 |
| Rodney F Hochman | Director | May 13, 2026 |
| Catherine A Lesjak | Director | May 11, 2026 |
| Kevin Lobo | Director | May 26, 2026 |
| Anne T Madden | Director | May 11, 2026 |
| William J Stromberg | Director | May 11, 2026 |
| Watkin Phoebe L. Yang | Director | May 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Peter J Arduini | President and CEO | Sep 4, 2026 |
| Jeannette Bankes | CEO, Patient Care Solutions | Sep 3, 2026 |
| Catherine Estrampes | Chief Commer. & Growth Officer | Sep 4, 2026 |
| William K Grogan | Chief Financial Officer | Sep 16, 2026 |
| Adam Y Holton | Chief People Officer | Sep 4, 2026 |
| Frank R Jimenez | GC & Corporate Secretary | Sep 4, 2026 |
| Taha Kass-Hout | Chief Technology Officer | Sep 4, 2026 |
| George A. Newcomb | Chief Accounting Officer | Sep 4, 2026 |
| Kevin Michael O'Neill | CEO, PDx | Sep 4, 2026 |
| Philip Rackliffe | CEO, AIS | Sep 4, 2026 |
| Roland Rott | CEO, Imaging | Mar 4, 2026 |
| James Saccaro | Chief Financial Officer | May 1, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 22, 2026 | Kevin Lobo | Buy | 10,000 | $64.18 |
| May 22, 2026 | Kevin Lobo | Buy | 10,000 | $64.18 |
| May 22, 2026 | Kevin Lobo | Buy | 10,000 | $64.18 |
| May 22, 2026 | Kevin Lobo | Buy | 10,000 | $64.18 |
| May 12, 2026 | Rodney F Hochman | Buy | 1,618 | $62.03 |
| May 12, 2026 | Rodney F Hochman | Buy | 1,618 | $62.03 |
| May 12, 2026 | Rodney F Hochman | Buy | 1,618 | $62.03 |
| May 12, 2026 | Rodney F Hochman | Buy | 1,618 | $62.03 |
| May 8, 2026 | Watkin Phoebe L. Yang | Buy | 1,000 | $63.01 |
| May 8, 2026 | Watkin Phoebe L. Yang | Buy | 1,000 | $63.01 |
| May 8, 2026 | Watkin Phoebe L. Yang | Buy | 1,000 | $63.01 |
| May 8, 2026 | Watkin Phoebe L. Yang | Buy | 1,000 | $63.01 |
| May 6, 2026 | H Lawrence Jr Culp | Buy | 80,805 | $61.88 |
| May 6, 2026 | H Lawrence Jr Culp | Buy | 80,805 | $61.88 |
| May 6, 2026 | H Lawrence Jr Culp | Buy | 80,805 | $61.88 |
GEHC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $20.62B | $2.08B | 4.55 | — |
| Dec 31, 2024 | $19.67B | $1.99B | 4.34 | — |
| Dec 31, 2023 | $19.55B | $1.57B | 3.03 | — |
| Dec 31, 2022 | $18.34B | $1.92B | 4.22 | — |
| Dec 31, 2021 | $17.59B | $2.25B | 4.95 | — |
Latest balance sheet: total assets $37.12B, total liabilities $26.23B, cash $2.26B (as of Mar 31, 2026).
GEHC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $71.90 |
| Jul 23, 2026 | 8-K Item 2.02 (results) | $61.99 |
| Apr 29, 2026 | 8-K Item 2.02 (results) | $59.49 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $82.63 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $77.38 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $71.64 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $70.33 |
| Feb 13, 2025 | 8-K Item 2.02 (results) | $93.48 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $87.20 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| Apr 30, 2024 | 8-K Item 2.02 (results) | — |
| Feb 6, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Butterfly Network (BFLY)Koninklijke Philips Nv (PHG)Nano-X Imaging (NNOX)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on GEHC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.